Revue de presse : articles récents utiles à la pratique pharmaceutique

M. Juste

Revue de presse : articles re´cents utiles a` la pratique pharmaceutique§

Rec¸u le : 30 septembre 2016 Accepte´ le : 30 septembre 2016

Disponible en ligne sur

ScienceDirect

Centre hospitalier Auban-Moe ¨t, 51200 E´pernay, France

www.sciencedirect.com

Longuet P, et al. Preparing and administering injectable antibiotics: how to avoid playing God. Med Mal Infect 2016;46:242–68 & Mallet L. La cascade me´dicamenteuse : comment la pre´venir, la de´tecter et re´soudre les proble`mes qu’elle engendre. Pharmactuel 2016;49:136–9 & Dinh, et al. Dure ´ e courte d’antibiothe´rapie. Rev Med Intern 2016;37:466–72 Parmi l’ensemble de cette se´lection, je vous propose ces trois articles particulie`rement inte´ressants, pour ne pas dire incontournables. Le premier contient une version anglaise et une version franc¸aise de donne´es de dilution et conservation de solutions d’antibiotiques utilisables en milieu hospitalier et en HAD. Le second de´crit le phe´nome`ne de cascade me´dicamenteuse, pie`ge the´rapeutique particulie`rement insidieux chez la personne aˆge´e. Le troisie`me fait une mise au point sur les e´tudes disponibles permettant de justifier des dure´es de traitement antibiotique raccourcis. Bonne lecture. &

Infectiologie &

&

&

&

&

&

&

& §

Tous les articles cite´s sont disponibles en acce`s libre ou Open Access sur les sites des revues.

http://dx.doi.org/10.1016/j.phclin.2016.10.001 2211-1042/

Publications re´centes

Stott KE, et al. Adequacy of rifampin absorption after jejunostomy tube administration. Pharmacotherapy 2016;36:e23–5 Smolders EJ, et al. Pharmacokinetics, efficacy and safety of hepatitis C virus drugs in patients with liver and/or renal impairment. Drug Saf 2016;39:589–611 Ferreira VL, et al. Safety of interferon-free therapies for chronic hepatitis C: a network metaanalysis. J Clin Pharm Ther 2016;41:478–85 Longuet P, et al. Preparing and administering injectable antibiotics: how to avoid playing God. Med Mal Infect 2016;46:242–68 Tran L, et al. Utilisation de la procalcitonine pour le diagnostic et le suivi du traitement des infections respiratoires au centre hospitalier de l’universite´ de Montre´al. Pharmactuel 2016;49:95–100 Tran L, et al. Usage de la procalcitonine pour guider l’utilisation des antibiotiques en cas de sepsis. Pharmactuel 2016;49:101–8 Dinh, et al. Dure´e courte d’antibiothe´rapie. Rev Med Intern 2016;37:466–72 Hessel MH, et al. Sofosbuvir and daclatasvir. Br J Clin Pharmacol 2016;82:878–9

&

Gulliford MC, et al. Safety of reduced antibiotic prescribing for self limiting respiratory tract infections in primary care: cohort study using electroning health records. Br Med J 2016;354:i3410

Ge´riatrie &

&

&

&

&

Hazra NC, et al. Drug utilization and inappropriate prescribing in centenarians. J Am Geriatr Soc 2016;64:1079–84 Jamerson BD, et al. A new method of identifying characteristics of needing help to take medications in an older representative community welling population: the older adults medication assist scale. J Am Geriatr Soc 2016;64:1195–202 Morin L, et al. Prevalence of potentially inappropriate medication use in older adults living in nursing homes: a systematic review. JAMDA 2016;17:862e1–862e9 Franchi C, et al. e-learning in order to improve drug prescription for hospitalized older patients: a clusterrandomized controlled study. Br J Clin Pharmacol 2016;82:53–63 Page AT, et al. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and metaanalysis. Br J Clin Pharmacol 2016;82:583–623

Le Pharmacien Hospitalier et Clinicien 2016;51:373-375

373

M. Juste &

Brown G. Prote´ger nos patients aˆge´s contre les re´actions inde´sirables aux me´dicaments. Can J Hosp Pharm 2016;69:267–8

Le Pharmacien Hospitalier et Clinicien 2016;51:373-375 &

&

He´mostase/He´matologie &

&

&

&

Song Y, et al. Evaluation of crushed tablet for oral administration and the effect of food on apixaban pharmacokinetics in healthy adults. Clin Ther 2016;38:1674–1685e1 Pilotto A, et al. Warfarin treatment and all-cause mortality in community dwelling older adults with atrial fibrillation: a retrospective observational study. J Am Geriatr Soc 2016;64:1416-24 Gomez-Outes A, et al. Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation: meta-analysis by geographic region with a focus on European patients. Br J Clin Pharmacol 2016;82:633–44 Peterson JF, et al. Physician response to implementation of genotype-tailored antiplatelet therapy. Clin Pharmacol Ther 2016;100:67–74

&

&

&

&

&

374

&

&

&

&

&

&

Iatroge´nie/Gestion des risques Rolfes L, et al. The impact of experiencing adverse drug reactions on the patient’s quality of life: a retrospective cross-sectional study in the Netherlands. Drug Saf 2016;39:769–76 Skilving I, et al. Statin-induced myopathy in a usual care setting – a prospective observational study of gender differences. Eur J Clin Pharmacol 2016;72:1171–6 Ferrer P, et al. Systematic review and meta-analysis: macrolides and amoxicilline/clavulanate induced acute liver injury. Basic Clin Pharmacol Toxicol 2016;119:3–9

Pharmacie clinique

Neurologie/Antalgie &

&

Renoux C, et al. Ventricular tachyarythmia and sudden cardiac death with domperidone use in Parkinson’s disease. Br J Clin Pharmacol 2016;82:461–72 Zheng-he Yu, et al. Use of antipsychotics and risk of myocardial infarction: a systematic review and meta-analysis. Br J Clin Pharmacol 2016;82:624–32 Abrahamsen BO, et al. Risk of hip, subtrochanteric and femoral shaft fractures among mid- and long-term users of alendronate: nationwide cohort and nested case-control study. Br Med J 2016;353:i3365 Barnett ML, et al. Adverse inpatient outcomes during the transition to a new electronic health record system: observational study. Br Med J 2016;354:i3835 Korhonen P, et al. Pioglitazone use and risk of bladder cancer in patients type 2 diabetes: retrospective cohort study using datasets from four European countries. Br Med J 2016;354:i3903

&

&

&

van Rongen A, et al. Morbidly obese patients exhibit increased CYP2E1 mediated oxidation of acetaminophen. Clin Pharmacokin 2016;55:833–47 Golembiewski J, et al. Evolution of patient-controlled analgesia: from intravenous to sublingual treatment. Hosp Pharm 2016;51:214229 Albert-Vartanian A, et al. Will peripherally restricted kappa-opioid receptor agonists (pKORAS) relieve pain with less opioid adverse effects and abuse potential? J Clin Pharm Ther 2016;41:371-82 De´ry-Neveu B, et al. Ketamine par voie orale pour le traitement du syndrome douloureux re´gional complexe re´fractaire d’une patiente de 36 ans. Pharmactuel 2016;49:109–14 [+Annexe]

Geurts MME, et al. Implications of a clinical medication review and a pharmaceutical care plan of polypharmacy patients with a cardiovascular disorder. Int J Clin Pharm 2016;38:808–15 Mallet L. La cascade me´dicamenteuse : comment la pre´venir, la de´tecter et re´soudre les proble`mes qu’elle engendre. Pharmactuel 2016;49:136–9 Hasunuma T, et al. Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three Asian populations and Caucasians. Br J Clin Pharmacol 2016;81:1078–90 Almanasreh E, et al. The medication reconciliation process and classification of discrepancies: a systematic review. Br J Clin Pharmacol 2016;82:645–58 Langer T, et al. Patients and families as teachers: a mixed methods assessment of a collaborative learning model for medical error disclosure and prevention. BMJ Qual Saf 2016;25:615–25 Stopfer P, et al. Pharmacokinetic evaluation of a drug transporter cocktail consisting of digoxin, furosemide, metformin and rosuvastatin. Clin Pharmacol Ther 2016;100:259–67

Cance´rologie &

&

Graham CN, et al. Economic analysis of panitumumab compared with cetuximab in patients with wildtype KRAS metastatic colorectal cancer that progresses after standard chemotherapy. Clin Ther 2016;38:1376–91 Ledermann JA, et al. Cediranib in patients with relapsed platinumsensitive ovarian cancer (ICON6): a randomized, double blind placebo controlled phase 3 trial. The Lancet 2016;387:1066–74

Revue de presse : articles re´cents utiles a` la pratique pharmaceutique &

&

James ND, et al. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapyin prostate cancer (ST AMPEDE): survival results from a adaptative, multiarm, multistage, platform randomized controlled trial. Lancet 2016;387:1163–77 Aminkeng F, et al. Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity. Br J Clin Pharmacol 2016;82:683–95

Toxicologie/Addictions &

Chen HY, et al. treatment of druginduced seizures. Br J Clin Pharmacol 2016;81:412–9

&

&

&

Thomas SH, et al. Pharmacological treatment of acquired QT prolongation and torsades de pointes. Br J Clin Pharmacol 2016;81:420–7 Chughlay MF, et al. N-acetylcysteine for non-paracetamol drug-induced liver injury: a systematic review. Br J Clin Pharmacol 2016;81:1021–9 Katselou M, et al. Fenethylline (Captagon) abuse – local problems from an old drug become universal. Basic Clin Pharmacol Toxicol 2016;119:133–40

&

&

preterm birth (the OPPTIMUM study): a multicenter, randomized double blind trial. Lancet 2016;387:2106–16 Tasnif Y, et al. Pregnancy-related pharmacokinetic changes. Clin Pharmacol Ther 2016;100:53–62 Alwan S, et al. Maternal use of selective-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. Clin Pharmacol 2016;100:34–41

Gyne´cologie/Grossesse/ Ne´onatalogie &

Norman JE, et al. Vaginal progesterone prophylaxis for

375